BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33660763)

  • 1. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
    Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin.
    Cao K; Li J; Zhao Y; Wang Q; Zeng Q; He S; Yu L; Zhou J; Cao P
    Mol Cells; 2016 Feb; 39(2):96-102. PubMed ID: 26743900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion.
    Cao K; Lu C; Han S; Zou Q; Li J; Xie D; He S; Yu L; Zhou J; Peng X; Cao P
    Int J Clin Exp Pathol; 2015; 8(1):551-9. PubMed ID: 25755745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5.
    Ke Y; Bao T; Zhou Q; Wang Y; Ge J; Fu B; Wu X; Tang H; Shi Z; Lei X; Zhang C; Tan Y; Chen H; Guo Z; Wang L
    Int J Cancer; 2017 Jul; 141(2):364-376. PubMed ID: 28390157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.
    Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
    Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
    Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
    Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
    Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
    Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
    Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Mei J; Wang R; Xia D; Yang X; Zhou W; Wang H; Liu C
    DNA Cell Biol; 2020 Oct; 39(10):1838-1849. PubMed ID: 32876480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism.
    Yu L; Sun Y; Li J; Wang Y; Zhu Y; Shi Y; Fan X; Zhou J; Bao Y; Xiao J; Cao K; Cao P
    J Exp Clin Cancer Res; 2017 Aug; 36(1):110. PubMed ID: 28810896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.